These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9579635)

  • 1. The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells.
    Stouffer GA; Runge MS
    Semin Thromb Hemost; 1998; 24(2):145-50. PubMed ID: 9579635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells.
    Cucina A; Borrelli V; Lucarelli M; Sterpetti AV; Cavallaro A; Strom R; Santoro-D'Angelo L; Scarpa S
    Cell Biochem Funct; 2002 Mar; 20(1):39-46. PubMed ID: 11835269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic factors released from smooth muscle cells are responsible for neointimal cell proliferation after balloon catheter deendothelialization.
    Li Z; Moore S; Alavi MZ
    Exp Mol Pathol; 1995 Oct; 63(2):77-86. PubMed ID: 8941042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.
    Kayanoki Y; Higashiyama S; Suzuki K; Asahi M; Kawata S; Matsuzawa Y; Taniguchi N
    Biochem Biophys Res Commun; 1999 May; 259(1):50-5. PubMed ID: 10334914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes.
    Ferns GA; Reidy MA; Ross R
    Am J Pathol; 1991 Apr; 138(4):1045-57. PubMed ID: 1849358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin induces production of growth factors from aortic smooth muscle cells.
    Cucina A; Borrelli V; Di Carlo A; Pagliei S; Corvino V; Santoro-D'Angelo L; Cavallaro A; Sterpetti AV
    J Surg Res; 1999 Mar; 82(1):61-6. PubMed ID: 10068527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
    J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture.
    Borrelli V; Sterpetti AV; Coluccia P; Randone B; Cavallaro A; Santoro D'Angelo L; Cucina A
    J Surg Res; 2001 Oct; 100(2):154-60. PubMed ID: 11592785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc potentiates the stimulation by basic and acidic fibroblast growth factors on the proliferation of cultured vascular smooth muscle cells.
    Fujiwara Y; Kaji T
    Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):95-106. PubMed ID: 9507572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids.
    Pagel CN; Song SJ; Loh LH; Tudor EM; Murray-Rust TA; Pike RN; Mackie EJ
    Bone; 2009 May; 44(5):813-21. PubMed ID: 19442625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis.
    McNamara CA; Sarembock IJ; Bachhuber BG; Stouffer GA; Ragosta M; Barry W; Gimple LW; Powers ER; Owens GK
    Semin Thromb Hemost; 1996; 22(2):139-44. PubMed ID: 8807710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors controlling the development of arterial lesions after injury.
    Reidy MA; Fingerle J; Lindner V
    Circulation; 1992 Dec; 86(6 Suppl):III43-6. PubMed ID: 1424050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors controlling smooth-muscle cell proliferation.
    Reidy MA
    Arch Pathol Lab Med; 1992 Dec; 116(12):1276-80. PubMed ID: 1456872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors and vascular smooth muscle cell growth responses.
    Delafontaine P
    Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2 (PAR-2).
    Bono F; Lamarche I; Herbert JM
    Biochem Biophys Res Commun; 1997 Dec; 241(3):762-4. PubMed ID: 9434782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic increase in nerve growth factor secretion by cultured vascular smooth muscle cells treated with injury-related growth factors.
    Creedon DJ; Tuttle JB
    J Neurosci Res; 1997 Feb; 47(3):277-86. PubMed ID: 9039650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
    Reilly CF; Fritze LM; Rosenberg RD
    J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration.
    Mii S; Ware JA; Kent KC
    Surgery; 1993 Aug; 114(2):464-70. PubMed ID: 8393599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thrombin, the thrombin receptor activation peptide, and other mitogens on vascular smooth muscle cell urokinase receptor mRNA levels.
    Reuning U; Little SP; Dixon EP; Bang NU
    Blood; 1994 Dec; 84(11):3700-8. PubMed ID: 7949125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism.
    Dabbagh K; Laurent GJ; McAnulty RJ; Chambers RC
    Thromb Haemost; 1998 Feb; 79(2):405-9. PubMed ID: 9493599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.